Tech Tuesday: University of Florida Startups Encouraged To Apply for Upcoming GatorPitch Event
In this edition of Tech Tuesday, UF Innovate's host Bethany Gaffey introduce Melissa Kuchma of UF Innovate, who encourages UF startups to apply to pitch in front of an audience of investors in the Miami area.
Solid Biosciences Reports Positive Initial Clinical Data From Next-Generation Duchenne Gene Therapy Candidate SGT-003
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced positive initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy candidate for treating Duchenne muscular dystrophy.
Evergen Launches AI-Powered Bone Graft Image Processing Software Developed in Partnership With University of Florida
Evergen, a leading CDMO and formerly known as RTI Surgical, a UF startup, announces the launch of new AI-powered image processing software to enhance the analysis of CT bone graft scans.
NovaBone Partners With BEGO for European Launch of Dental Putty With Cartridge Dispenser at IDS 2025
UF startup NovaBone Products has announced a strategic distribution partnership with BEGO, a renowned provider of innovative implantology solutions.
Orangetheory Fitness Partners With Molekule, Bringing Advanced Air Purification Technology to Studio Locations
UF startup Molekule partnered with Orangetheory Fitness to provide medical-grade air purifiers, enhancing healthier and safer environments.
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing
UF startup Cannabix Technologies announced it has entered into an MOU with AlcoPro to collaborate on marketing efforts for the Cannabix Marijuana Breathalyzer in the U.S.
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
Solid Biosciences Inc., a life sciences company that acquired UF startup AavantiBio, announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SGT-212, the Company’s, AAV-based gene therapy candidate for the treatment of Friedreich’s ataxia (FA).
Rise Therapeutics Receives FDA IND Clearance To Initiate Clinical Testing of R-5780 in Cancer
UF startup Rise Therapeutics announced that the U.S. FDA has accepted its investigational new drug (IND) application to proceed with a cancer Phase 1 clinical trial for its program candidate, R-5780.
Caidya: Clinical Research Organization Raises $165 Million
Caidya, formed through the merger of dMed and UF startup Clinipace, announced the closing of a $165 million strategic growth investment from funds managed by Rubicon Founders, a U.S.-based healthcare investment firm focused on building transformational companies.
Genascence Announces Six-Month Results From Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, announced positive interim safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001.
